Rubella

Seminars in Fetal and Neonatal Medicine

Volumn 12, Issue 3, 2007, Pages 182-192

  Best, Jennifer M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Congenital abnormalities; Congenital rubella syndrome; Immunisation; Immunoglobulin M; Laboratory techniques; Prenatal diagnosis; Rubella virus

Indexed keywords

IMMUNOGLOBULIN M; MEASLES VACCINE; MUMPS VACCINE; RUBELLA ANTIBODY; RUBELLA VACCINE;

ARTHRALGIA; ARTHRITIS; ARTHROPATHY; BRAIN DISEASE; CLINICAL FEATURE; DEVELOPED COUNTRY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE PREDISPOSITION; GESTATIONAL AGE; HEALTH CARE PERSONNEL; HUMAN; IMMUNE RESPONSE; LABORATORY TEST; LYMPHADENOPATHY; NEWBORN DISEASE; PREGNANCY; PREGNANT WOMAN; PRENATAL DIAGNOSIS; RASH; REINFECTION; REVIEW; RISK FACTOR; RUBELLA; SEROLOGY; SYMPTOMATOLOGY; TREATMENT CONTRAINDICATION; VACCINATION; VIRUS ISOLATION; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA; RUBELLA VACCINE;

EID: 34247566650     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.01.017     Document Type: Review

References (67)

1. World Health Organisation. Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol Rec 80 (2005) 125-132
2. Cutts F.T., Robertson S.E., Diaz-Ortega J.-L., and Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 1: burden of disease from CRS. Bull World Health Organ 75 (1997) 55-68
3. Robertson S.E., Cutts F.T., Samuel R., and Diaz-Ortega J.-L. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 2: vaccination against rubella. Bull World Health Organ 75 (1997) 69-80
4. World Health Organisation. Report of a meeting on preventing congenital rubella syndrome: immunization strategies, surveillance needs (2000), WHO, Geneva. http://www.who.int/vaccines-documents Unpublished document WHO/V&B/00
5. Robertson S.E., Featherstone D.A., Gacic-Dobo M., and Hersh B.S. Rubella and congenital rubella syndrome: global update. Pan Am J Public Health 14 5 (2003) 306-315
6. Adler S., and Koch W.C. Human parvovirus infections. In: Remington J.S., Klein J.O., Wilson C.B., and Baker C.J. (Eds). Infectious diseases of the fetus and newborn infant. 6th ed. (2006), Elsevier Saunders, Philadelphia 868-892
7. Banatvala J.E., and Brown D.W.G. Rubella. Lancet 363 (2004) 1127-1137
8. Enders G., Nikerl-Pacher U., Miller E., and Cradock-Watson J.E. Outcome of confirmed periconceptional maternal rubella. Lancet 1 (1988) 1445-1447
9. Miller E., Cradock-Watson J.E., and Pollock T.M. Consequences of confirming maternal rubella at successive stages of pregnancy. Lancet 2 (1982) 781-784
10. Morgan-Capner P., Miller E., Vurdien J.E., and Ramsay M.E. Outcome of pregnancy after maternal reinfection with rubella. Commun Dis Rep (Lond Engl Rev) 1 6 (1991) R57-R59
11. Morgan-Capner P., and Crowcroft N.S. PHLS Joint Working Party of the Advisory Committees of Virology and Vaccines and Immunisation, Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). Commun Dis Public Health 5 (2002). http://www.hpa.org.uk/infections/topics_az/pregnancy/rashes/default.htm 59-71
12. Best JM & Enders G. Laboratory diagnosis of rubella and congenital rubella. In: Banatvala JE, Peckham C, editors. Rubella viruses. Perspectives in medical virology, vol. 15. London: Elsevier; 2007. p. 39-77.
13. Ramsay M., Reacher M., O'Flynn C., et al. Causes of morbilliform rash in a highly immunised English population. Arch Dis Child 87 (2002) 202-206
14. Best J.M., O'Shea S., Tipples G., et al. Interpretation of rubella serology in pregnancy-pitfalls and problems. Br Med J 325 (2002) 47-48
15. Best J.M., Banatvala J.E., Morgan-Capner P., and Miller E. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. Br Med J 299 (1989) 773-775
16. Bailão L.A., Osborne N.G., Rizzi M.C.S., Bonilla-Musoles F., Duarte G., and Sicchieri Bailão T.C.R. Ultrasound markers of fetal infection Part 1. Viral infections. Ultrasound Q 21 (2005) 295-308
17. Bosma T.J., Corbett K.M., Eckstein M.B., et al. Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 33 (1995) 2881-2887
18. Macé M., Cointe D., Six C., et al. Diagnostic value of reverse transcription-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection. J Clin Microbiol 42 10 (2004) 4818-4820
19. Enders G., Bäder U., Lindemann L., et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 5 (2001) 362-377
20. Tang J.W., Aarons E., Hesketh L.M., et al. Prenatal diagnosis of congenital rubella infection in the second trimester of pregnancy. Prenat Diagn 23 (2003) 509-512
21. Tookey P. Rubella in England, Scotland and Wales. Euro Surveill 9 4 (2004) 21-23
22. Centers for Disease Control and Prevention (CDC). Imported case of congenital rubella syndrome-New Hampshire, 2005. Morbid Mortal Wkly Rep 54 45 (2005) 1160-1161
23. Robert-Koch-Institut. Bekämpfung der Masern und konnatalen Röteln: WHO-Strategie in der europäischen Region und aktueller Stand in Deutschland. Epidem Bull 10 (2004) 79-84
24. Hahné S., Macey J., Tipples G., et al. Rubella outbreak in an unvaccinated religious community in the Netherlands spreads to Canada. Euro Surveill 10 4-6 (2005) 125-127
25. Vyse A.J., Gay N.J., White J.M., et al. Evolution of surveillance of measles, mumps and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev 24 (2002) 125-136
26. Hanshaw J.B., Dudgeon J.A., and Marshall W.C. Viral diseases of the fetus and newborn. 2nd ed. (1985), Saunders, Philadelphia, London, Toronto
27. Cooper L.Z., and Alford C.A. Rubella. In: Remington J.S., Klein J.O., Wilson C.B., and Baker C.J. (Eds). Infectious diseases of the fetus and newborn infant. 6th ed. (2006), Elsevier, Saunders, Philadelphia 894-926
28. Ueda K., Nishida Y., Oshima K., and Shepard T.H. Congenital rubella syndrome: correlation of gestational age at time of maternal rubella with type of defect. J Pediatr 94 (1979) 763-765
29. Munro N.D., Sheppard S., Smithells R.W., Holzel H., and Jones G. Temporal relations between maternal rubella and congenital defects. Lancet 2 (1987) 201-204
30. Menser M.A., and Forrest J.M. Rubella: high incidence of defects in children considered normal at birth. Med J Aust 1 (1974) 123-126
31. Best J.M., and Banatvala J.E. Rubella. In: Zuckerman A.J., Banatvala J.E., Griffiths P., Pattison J.R., and Schoub B. (Eds). Principles and practice of clinical virology. 5th ed. (2004), John Wiley & Sons, Chichester 427-457
32. Töndury G., and Smith D.W. Fetal rubella pathology. J Pediatr 68 (1966) 867-879
33. Lee J.-Y., and Bowden D.S. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 13 (2000) 571-587
34. Best J.M., Cooray S., and Banatvala J.E. Rubella. In: Mahy B.W.J., and ter Meulen V. (Eds). Topley & Wilson's microbiology and microbial infections: virology volume. 10th ed. (2005), Hodder Arnold, London 959-992
35. O'Shea S., Best J.M., and Banatvala J.E. A lymphocyte transformation assay for the diagnosis of congenital rubella. J Virol Methods 37 (1992) 139-148
36. Miller E, Tookey P, Morgan-Capner P, et al. Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev 1994;4:R146-52.
37. World Health Organisation. Guidelines for surveillance of congenital rubella syndrome and rubella. Field test version (1999), WHO, Geneva WHO/V&B/99.22
38. Reef S.E., Plotkin S., Cordero J.F., et al. Preparing for elimination of congenital rubella syndrome (CRS): Summary of a Workshop on CRS elimination in the United States. Clin Infect Dis 31 (2000) 85-95
39. World Health Organisation. Surveillance guidelines for measles and congenital rubella infection in the WHO European Region (2003), World Health Organization, Copenhagen
40. Eckstein M.B., Brown D.W.G., Foster A., Richards A.F., Gilbert C.E., and Vijayalakshmi P. Congenital rubella in south India: diagnosis using saliva from infants with cataract. Br Med J 312 (1996) 161
41. Corcoran C., and Hardie D.R. Serologic diagnosis of congenital rubella: a cautionary tale. Pediatr Infect Dis J 24 3 (2005) 286-287
42. Cooper L.Z., Florman A.L., Ziring P.R., and Krugman S. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine. Am J Dis Child 122 (1971) 397-403
43. Forrest J.M., Turnbull F.M., Sholler G.F., et al. Gregg's congenital rubella patients 60 years later. Med J Aust 177 (2002) 664-667
44. Peckham C.S. Clinical and serological assessment of children exposed in utero to confirmed maternal rubella. Br Med J 2 (1974) 259-261
45. Plotkin S.A. Rubella vaccine. In: Plotkin S., and Orenstein W.A. (Eds). Vaccines. 3rd ed. (1999), Saunders, Philadelphia 409-439
46. Reef S, Plotkin S. Rubella vaccines. In: Banatvala JE, Peckham C, editors. Rubella viruses, Perspectives in medical virology, vol. 15. London: Elsevier. 2007. p. 79-93.
47. Department of Health. Rubella. In: Salisbury D., Ramsay M., and Noakes K. (Eds). Immunisation against infectious disease-"The Green Book" (2006), The Stationary Office, London. http://www.dh.gov.uk/assetRoot/04/13/79/28/04137928.pdf Chapter 28. Available at:
48. Centers for Disease Control. Rubella. In: Atkinson W., Hamborsky J., McIntyre L., and Wolfe S. (Eds). Epidemiology and prevention of vaccine-preventable diseases. 9th ed. (2006), Public Health Foundation, Washington DC. http://www.cdc.gov/nip/publications/pink/rubella.pdf Available at
49. O'Shea S., Best J.M., Banatvala J.E., and Shepherd W.M. Development and persistence of class-specific serum and nasopharyngeal antibodies in rubella vaccinees. J Infect Dis 151 1 (1985) 89-98
50. Miller E. MMR vaccine-worries are not justified. Commentary. Arch Dis Child 85 (2001) 273-274
51. Horton R. The lessons of MMR. Lancet 363 (2004) 747-750
52. Katz S.L. Has the measles-mumps-rubella vaccine been fully exonerated?. Pediatrics 118 (2006) 1744-1745
53. Centers for Disease Control and Prevention (CDC). Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. Morbid Mortal Wkly Rep 50 No. 49 (2001) 1117
54. da Silva e Sa G.R., Camacho L.A.B., Siqueira M.M., Stavola M.S., and Ferreira D.A. Seroepidemiological profile of pregnant women after inadvertent rubella vaccination in the state of Rio de Janeiro, Brazil, 2001-2002. Rev Panam Salud Publica 19 6 (2006) 371-378
55. Hinman A.R., Irons B., Lewis M., and Kandola K. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ 80 (2002) 264-270
56. Kaneko M., Sameshima H., Ikenoue T., et al. Rubella outbreak on Tokunoshima Island in 2004: serological and epidemiological analysis of pregnant women with rubella. J Obstet Gynaecol Res 32 5 (2006) 461-467
57. Robinson J.L., Lee B.E., Preiksaitis J.K., Plitt S., and Tipples G.A. Prevention of congenital rubella syndrome-what makes sense in 2006?. Epidemiol Rev 28 (2006) 81-87
58. Dayan G.H., Castillo-Solorzano C., Nava M., et al. Efforts at rubella elimination in the United States: the impact of hemispheric rubella control. Clin Infect Dis 43 (2006) S150-S163
59. World Health Organisation. Preventing congenital rubella syndrome. Wkly Epidemiol Rec 75 (2000) 290-295
60. Castillo-Solorzano C., and Andrus J.K. Rubella elimination and improving health care for women. Emerg Infect Dis 10 (2004) 2017-2021
61. Best J.M., Castillo-Solorzano C., Spika J., et al. Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee on Research related to measles and rubella vaccines and vaccination, June 2004. J Infect Dis 192 (2005) 1890-1897
62. World Health Organisation. Progress towards elimination of measles and prevention of congenital rubella infection in the WHO European Region, 1990-2004. Wkly Epidemiol Rec 80 8 (2005) 66-71
63. World Health Organisation. Global measles and rubella laboratory network-update. Wkly Epidemiol Rec 80 44 (2005) 384-388
64. Department of Health. Screening for infectious diseases in pregnancy. standards to support the UK Antenatal Screening Programme (2003), The Stationary Office, London. http://www.dh.gov.uk/assetRoot/04/09/20/49/04092049.pdf Available at
65. Tookey P.A., Cortina-Borja M., and Peckham C.S. Rubella susceptibility among pregnant women in North London. J Public Health Med 24 3 (2002) 211-216
66. Skendzel L.P. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 106 2 (1996) 170-174
67. In: Mahy B.W.J., and ter Meulen V. (Eds). Topley & Wilson's microbiology and microbial infections: virology volume. 10th ed. (2005), Hodder Arnold, London